PCAD Sponsors Mission Statements

miR Scientific Is Transforming Cancer Management Into What It Should Be.

miR Scientific is a precision bioscience company offering non-invasive liquid biopsy urine tests that accurately detect and precisely classify prostate and bladder cancers at the molecular level with industry-leading Sensitivity and Specificity.

Our molecular diagnostic capabilities approach cancer detection, classification, and monitoring through a new lens with advanced sncRNA interrogation techniques, a proprietary scoring algorithm, and innovative clinical decision support tools.
‍
The miR Disease Management Platform delivers breakthrough ease and accuracy of cancer diagnosis and characterization with actionable clinical pathways across the continuum of care.

At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities.

As a technology company, we – and our brand licensees – innovate for people with one consistent belief: there’s always a way to make life better.

Pfizer Oncology strives to advance the frontiers of cancer biology and to translate this knowledge into high-impact medicines for cancer patients. Our core areas of interest include: Tumor Cell Biology; Precision Medicine; Tumor Targeted Therapeutics; Integrative Biotechnology; and Immuno- Oncology. In Tumor Cell Biology we are focused on oncogenic drivers, tumor metabolism, and epigenetics. Precision Medicine represents an integrated cluster of technology platforms and translational science configured to enable patient-tailored, hypothesis-driven experimental medicine approaches. Our Integrative Biotechnology Group supports novel target identification and validation through functional genomics, proteomics, and other “omic” approaches.

Blue Earth Diagnostics is an established molecular imaging company on a growth trajectory to provide innovative, well differentiated diagnostics solutions, informing patients and driving future therapies in cancer. Formed in 2014, Blue Earth Diagnostics success is driven by our management expertise and agility, supported by our demonstrated track record of rapid development and commercialization of PET radiopharmaceuticals. Blue Earth Diagnostics’ clinical focus is exclusively in cancer.

AAA is an innovative medicines company focused on the development of products for targeted radioligand therapy and precision radioligand imaging.

Clovis Oncology is on a Mission to Advance the Fight Against Cancer

Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.

Ongoing innovation. Scientific Advancement. Enduring relationships.

DxTx Medical is focused on improving outcomes with specialized accessories for medical radiology applications. Our medical device products help radiologists and urologists with enhanced imaging offering additional treatment options benefiting the patient. DxTx Medical delivers quality products assisting clinicians with better tools.

Since it was founded in 1979, EDAP TMS has been committed to introducing new and innovative technologies for a minimally-invasive approach to treating urological disorders.

We’re always looking forward. While our roots started in solutions for urology applications, today our minimally invasive, mobile technology can be used in a variety of clinical applications. From treating cancerous tumors to kidney stones to nerve monitoring we have a solution…and we’re not stopping there.

At Exact Imaging, we’re building a fast-moving, customer-focused team that is developing novel imaging technologies to make a difference in clinical practice and eventually in patient care. We are committed to building a work environment where smart, inquisitive, collaborative, and results-driven individuals can contribute meaningfully to the growth of our products, customer solutions and to our business globally.

Originally set by Hitachi founder Namihei Odaira, the Mission has been carefully passed on to generations of employees and stakeholders throughout the company’s 100-year history. The Values reflect the Hitachi Founding Spirit, which was shaped by the achievements of our company predecessors as they worked hard to fulfill Hitachi’s Mission. The Vision has been created based on the Mission and Values. It is an expression of what the Hitachi Group aims to become in the future as it advances to its next stage of growth.

The Mission, Values and Vision are made to be shared in a simple concept: Hitachi Group Identity.

As the specialty care global business unit of Sanofi, our work is focused in the areas of rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. Each day we continue to advance new therapies, demonstrating our commitment to making a positive impact on the lives of patients around the world.

KOELIS mission is to provide clinicians with quality control at every step of the prostate cancer management and to streamline workflow by providing a patient-tailored, high-detailed, updatable prostate cartography that is stored and shared for promoting multidisciplinary shared decisions. Based on the value of 3D imaging, organ-based tracking fusion™ and mapping,  KOELIS helps urologists and radiologists to gain confidence and precision in diagnosis and active surveillance as well as planning and performing guided targeted treatments.

Lantheus is a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products that help healthcare professionals identify disease and improve patient treatment and care. Our pioneering products assist physicians in the diagnosis and treatment of conditions affecting the heart, brain, lungs and other organs using echocardiography, nuclear imaging, radiotherapeutics, and targeted PET imaging agents.